| SATURDAY MARCH 25, 2023 | HALL A | |
 | |
| 07:30-08:30 | Ocular Therapeutix Industry Sponsored Breakfast Symposium: Emerging Sustained-Release TKI Therapies to Address the Unmet Need in nAMD and other retinal vascular diseases |
| Chair: | Peter Kaiser, USA |
| 07:30 | Welcome and Opening Remarks Peter Kaiser, USA |
| 07:35 | Unmet need in current approaches for nAMD and other retinal vascular diseases Paolo Lanzetta, Italy |
| 07:45 | Emerging therapies: TKI and sustained-release innovation Anat Loewenstein, Israel |
| 07:55 | TKI: Pre-clinical & Clinical findings Peter Kaiser, USA |
| 08:10 | Discussion: Looking into the future – The paradigm shift for retinal vascular diseases Audience Q&A with Panel |
| 08:25 | Closing Remarks Peter Kaiser, USA |
